Browse by Audience
Skip to content
Papers of the Week
Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China.
Authors
Abstract
Although the inactivated SARS-CoV-2 vaccine (CoronaVac) has undergone preclinical tests and clinical trials evaluating its efficacy and safety before being approved for authorization, few data have been reported in the post-licensure real-world setting. We aimed to assess the safety of the vaccine among healthcare workers.